Know the early warning signs of metabolic syndrome—a growing problem
Patients who have metabolic syndrome are at higher risk of multiple chronic conditions, including diabetes, coronary heart disease, cancer, and stroke. Metabolic syndrome has become increasingly common: its prevalence has risen in every sociodemographic group, and today it is estimated that more than a third of adults in the United States have metabolic risk.1
Some factors contributing to metabolic syndrome are genetic, while others can be modified with lifestyle changes. Quest Diagnostics offers a full range of testing options to help evaluate patients’ metabolic and cardiovascular risk, so physicians can take action to help prevent or delay onset of chronic conditions, and prevent adverse events such as stroke.
Metabolic testing from Quest Diagnostics
Quest offers a full complement of tests, from routine to advanced, to help you obtain the most complete picture possible of your patient’s risk of metabolic syndrome.
Metabolic tests
Diabetes tests
Complementary vitamin and supplement tests
Get the early warning signs. Learn more about our metabolic testing and more.
Identify the risk of metabolic syndrome
Quest offers a full complement of tests, from routine to advanced, to help you obtain the most complete picture possible of your patient’s risk of metabolic syndrome.
This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.
References
- Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988–2012. Prev Chronic Dis. 2017;14:e24. doi:10.5888/pcd14.160287
Questions?
Your Quest account representative can provide additional information on our cardiovascular testing solutions.
Cardiovascular disease
Cardiovascular
-
Advanced lipid testing -
Identifying residual risk -
Inflammation testing -
Advanced inflammatory marker testing -
Metabolic testing -
Metabolic testing portfolio -
Cardiogenetic testing -
Heart failure -
Focus on earlier identification of heart failure risk -
Non-lipid markers for CVD -
Important genotyping -
CVD test descriptions -
4myheart® program -
Cardio IQ® report -
Early identification of CVD risk in women
Save time & fix billing issues
Avoid disruptions and reduce paperwork with electronic billing trailers.
Raise patient satisfaction and get the insights you need
Access better patient tools, view test offerings, improve your bottom line, and more.
- Site map
- Privacy Notices
- Terms
- Contact us
- Language assistance / non-discrimination
- Asistencia de idiomas / Aviso de no discriminación
- 語言協助 / 不歧視通知
- Accessibility
-
Your Privacy Choices
Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.
Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.